相关实验视频
Updated: Jan 17, 2026

11:13
Using Mouse Oocytes to Assess Human Gene Function During Meiosis I
Published on: April 10, 2018
9.4K
NAD+前体减轻体外和体内生殖缺陷:局限性和可能的解决方案
Nazli Pinar Arslan1, Zuleyha Akpinar2, Havva Aybek1
1Vocational School of Health Services, Bingol University, Bingol, Turkey.
Reproductive toxicology (Elmsford, N.Y.)
|September 21, 2025
概括
尼古丁胺胺氨基二核酸 (NAD+) 前体保护哺乳动物的生殖健康,防止衰老和疾病. 补充改善生育能力和胚胎发育,突出了针对药物输送系统的潜力.
科学领域:
- 细胞生物学 细胞生物学
- 生殖科学 生殖科学
- 生物化学 生物化学
背景情况:
- 尼古丁胺胺氨基二核酸 (NAD+) 对于细胞过程至关重要,包括能量生产,DNA修复和炎症.
- 随着衰老,疾病和毒素暴露,NAD+水平下降,对哺乳动物的生殖参数产生负面影响.
- 在减轻这些对生育和发育的有害影响方面,NAD+前体显示出有前途.
研究的目的:
- 审查NAD+前体在保护哺乳动物生殖健康中的作用.
- 总结NAD+前体对体内和体外生殖参数的影响.
- 确定未来的研究方向,特别是针对NAD+前体的药物输送系统.
主要方法:
- 关于NAD+及其前体在哺乳动物繁殖中的研究的文献综述.
- 对NAD+前体对生殖结果的影响数据的分析.
- 确定关于针对性提供NAD+前体的研究缺口.
主要成果:
- 在体内,NAD+前体可以防止或减少衰老,疾病和毒素对生殖参数的有害影响.
- 补充NAD+前体可以提高卵细胞和精子质量,改善体外受精和胚胎发育.
- NAD+前体可以防止冷保存损伤和对生殖细胞的有毒侮辱.
结论:
- 在各种条件下,NAD+前体有效地保护和增强哺乳动物的生殖功能.
- 针对NAD+前体的向药物递送系统,可能利用激素受体或TPP+用于器官向,是未来研究的一个有希望的领域.
- 建议对NAD+载荷药物输送系统进行进一步调查,以优化生殖健康干预措施.
相关概念视频
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
In-vitro Mutagenesis
16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Nondisjunction
4.8K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers. Nondisjunction is common during anaphase I or anaphase II of meiosis. Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
4.8K
Meiosis I
43.8K
Meiosis is the division of a diploid cell into haploid cells forming sperm and eggs in animals through differentiation. Meiosis I is the first stage of meiosis, where the genetic recombination of homologous chromosomes and the reduction of the ploidy level by half occurs.
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
43.8K

